CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard? Wolff AC. J Clin Oncol 2020 Sep 20:JCO2002688. doi: 10.1200/JCO.20.02688.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wolff AC. CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard? J Clin Oncol 2020 Sep 20:JCO2002688. doi: 10.1200/JCO.20.02688.
PMID: 32954928